Kidney Transplantation in Patients With Active Multiple Myeloma: Case Reports

Abstract

Kidney disease is a common complication in patients with multiple myeloma. Traditionally, patients with active multiple myeloma and end-stage renal disease have been excluded from kidney transplantation due to the risk of malignancy progression. The introduction of bortezomib-based therapy for patients with multiple myeloma and renal impairment has significantly improved survival in this population. In this report, we present 2 cases of patients with active and controlled multiple myeloma who underwent successful kidney transplantation without progression of their underlying malignancy. In patients with active multiple myeloma controlled with bortezomib, kidney transplantation should be considered a valid option for patients with end-stage kidney disease.

DOI: 10.1097/TXD.0000000000000716

2 Figures and Tables

Cite this paper

@inproceedings{Lum2017KidneyTI, title={Kidney Transplantation in Patients With Active Multiple Myeloma: Case Reports}, author={Erik Lawrence Lum and Neil M Kogut and Thu Phuong Pham and Gabriel M. Danovitch and Suphamai Bunnapradist}, booktitle={Transplantation direct}, year={2017} }